The Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.

PROGRESS IN RETINAL AND EYE RESEARCH, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to the advancement of knowledge in the fields of ophthalmology and sensory systems. With an impressive impact factor and a Q1 category ranking in both Ophthalmology and Sensory Systems as of 2023, this journal exemplifies excellence in research dissemination. Given its stature, it ranks #1 out of 137 in Ophthalmology and #1 out of 42 in Neuroscience - Sensory Systems, placing it within the top percentile of scientific publications in these domains. The journal has been actively contributing to the field since its inception in 1994 and continues to be a vital resource for researchers, clinicians, and students seeking the latest insights and breakthroughs in the understanding of retinal diseases and eye health. While it maintains a traditional subscription model, the journal remains committed to publishing high-quality, peer-reviewed articles that drive forward the frontiers of eye research and therapeutic innovation. With its strong scientific rigor and a vast array of articles, PROGRESS IN RETINAL AND EYE RESEARCH is indispensable for anyone invested in the study of visual sciences.

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

Turk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.

Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

Japanese Journal of Ophthalmology, published by Springer Japan KK, is a premier peer-reviewed journal dedicated to advancing the field of ophthalmology. With an impressive impact reflected in its Q1 categories—ranking among the top journals in both Medicine (miscellaneous) and Ophthalmology, as per the 2023 metrics—it serves as an essential platform for researchers and professionals to disseminate their findings. Covering a broad spectrum of topics from clinical studies to innovative technologies in eye care, this journal not only supports the ongoing education of its readership but also fosters significant developments within the field. The journal, which has been in circulation since 1973 and is set to continue through 2024, offers access to vital research, thereby enabling practitioners and scholars to keep abreast of the latest advancements. Its distinguished Scopus ranking of #30 out of 137 in Medicine - Ophthalmology, placing it in the 78th percentile, further underscores its influence and importance in contributing to the global understanding of eye health.

Ocular Immunology and Inflammation is a distinguished academic journal dedicated to advancing the field of ocular immunology and ophthalmic inflammation. Published by Taylor & Francis Inc, this journal plays a crucial role in disseminating high-quality research findings, reviews, and clinical studies that address the complexities of immune responses in the eye and their implications in various ocular diseases. With an impressive impact factor and consistently ranking in the Q2 category in both Immunology and Allergy and Ophthalmology, it stands out as a vital resource for researchers, clinicians, and students alike. The journal's broad scope encompasses both experimental and clinical studies, ensuring a comprehensive exploration of the mechanisms and treatments of ocular inflammatory conditions. With its publication history dating from 1993 to 2024, this journal continues to be an essential reference for those seeking cutting-edge research and insights into ocular health. Researchers and professionals are encouraged to engage with the latest articles to inform their practice and advance their knowledge in this critical area of medicine.